507 results
8-K
EX-10.1
ORKA
Oruka Therapeutics Inc.
4 Oct 24
Departure of Directors or Certain Officers
4:05pm
of the applicable plans and programs, to participate in the employee benefits and insurance programs generally made available to the Company’s full-time employees … . Details of such benefits programs, including applicable employee contributions and waiting periods, if applicable, will be made available to you
8-K
EX-10.2
ORKA
Oruka Therapeutics Inc.
4 Oct 24
Departure of Directors or Certain Officers
4:05pm
Time Off. You will continue to be eligible, subject to the terms of the applicable plans and programs, to participate in the employee benefits … and insurance programs generally made available to the Company’s full-time employees. Details of such benefits programs, including applicable employee
8-K
EX-10.1
ORKA
Oruka Therapeutics Inc.
13 Sep 24
Oruka Therapeutics Announces $200 Million Private Placement
4:02pm
and as in effect on the Closing Date.
“Benefit Plan” or “Benefit Plans” means employee benefit plans as defined in Section 3(3) of ERISA and all other … employee benefit practices or arrangements, including, without limitation, any such practices or arrangements providing severance pay, sick leave
8-K
EX-10.2
ORKA
Oruka Therapeutics Inc.
13 Sep 24
Oruka Therapeutics Announces $200 Million Private Placement
4:02pm
against any current or future director, officer, employee, stockholder, general or limited partner or member of the Investors or of any affiliates … be incurred by any current or future director, officer, employee, stockholder, general or limited partner or member of the Investors or of any affiliates
8-K
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
A Preferred Stock, (iii) 2,063,669 options exercisable for shares of Oruka Common Stock, (iv) 5,345,336 Oruka employee warrants and (v) the Pre-Closing … outstanding (assuming the exercise in full of all Company pre-funded warrants and not including outstanding employee and director equity awards nor preferred
8-K
EX-3.5
qsq94dhh0u
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-10.11
wqak l9o3rv
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-99.4
480nk5orm3lq
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-10.10
yfrit1r5uw5ywkhq 2f
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-99.5
tgco 9dif
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-10.25
kufx1sxi cci60
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-3.6
akfh03a 32d3wtbb
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-99.3
0y1momzszlx4fowb6ljp
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-14.1
chc i3osr
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-10.16
kpbftlep829xuq9ue24p
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-99.1
sgpy2k15z9j14i 5u
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-99.1
euui6t6qvs xfv0knf
23 Aug 24
ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka Therapeutics
4:35pm
8-K
h3cnwttv
23 Aug 24
ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka Therapeutics
4:35pm
424B3
uzti0w2x
1 Aug 24
Prospectus supplement
4:10pm